Friday October 5th

 

Friday October 5th, Palais de l’Europe, Menton

Presentations are available for viewing in PDF format but should not be used without authors’ permission

08.00 – 11.00: Poster discussion session

08.00 – 09.30: Interim PET in lymphoma

Chairmen: B. Cheson, T. Vander Borght

      • Interim PET – technical issues (T. Vander Borght) 
      • Interim PET – clinical issues (B. Cheson) 
      • Interim PET in MCL (J.P. Vuillez)
      • Interim PET in MCL (A. Avigdor) 
      • Interim PET in advanced vs. early-stage HL (E.J. Dann) 
      • Interim PET in HL (Z. Miltényi)

09.30 – 11.00: PET in lymphoma

Chairmen: U. Dührsen, L. Kostakoglu

<

      • Baseline and end-of-treatment PET – clinical issues (U. Dührsen) 
      • PET in DLBCL (T.P. Vassilakopoulos)
      • PET in CNS lymphoma (S. Cimarelli)
      • PET in PMBCL (L. Ceriani) 
      • Baseline and end-of-treatment PET – technical issues (L. Kostakoglu) 
      • PET and BMB in DLBCL (J.J. Cerci)
      • Immuno PET/CT and BMB (K. Muylle)

11.00 – 11.30: Coffee break

11.30 – 13.00: Metabolic volume measurements in lymphoma

Chairmen: A. Versari, R. Boellaard, M. Meignan, L. Schwartz

Metabolic volume measurement (physics and methods)
R. Boellaard
 

Volume measurement with CT
L. Schwartz
 

Metabolic volume measurement methodology and clinical results (FIL and LYSA)
A. Versari , M. Sasanelli, E. Itti, M. Meignan
 

13.00 – 14.00: Lunch

14.00 – 15.00: FIL and LYSA ongoing programs with decisional interim PET

Chairmen: D. Caballero, O. Couturier

M. Federico (FIL)  and R.O. Casasnovas (LYSA) 

15.00 – 16.30: Interim PET in lymphoma 2012 consensus

Chairmen: C. Haioun, L. Kostakoglu 

A. Gallamini , A. Biggi , S. Barrington, E. Itti , M. Meignan, S. Müller